Abstract Detail

A detailed view of abstract

Schedule preview
Overcoming manufacturing bottlenecks to accelerate clinical trial supply chains.

Scalable Synthesis Pipelines for Next-Generation Antibody-Drug Conjugates

Dr. Elena Rostova · Switzerland

This presentation highlights a newly optimized, automated bioreactor system that doubles the yield of target monoclonal antibodies while minimizing batch-to-batch impurities. By refining the link technology, this scalable framework ensures highly stable conjugate delivery, drastically reducing production overhead for precision oncology therapeutics.